NCT03038607View on ClinicalTrials.gov

Aspirin in Asymmetrically Intrauterine Growth

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

January 31, 2017

Study Completion Date

January 31, 2017

Conditions
Intrauterine Growth Restriction Asymmetrical
Interventions
DRUG

Aspirin

This group were subjected to aspirin 75 mg once daily for 6 weeks.

Trial Locations (1)

71111

Women Health Hospital - Assiut university, Asyut

All Listed Sponsors
lead

Assiut University

OTHER

NCT03038607 - Aspirin in Asymmetrically Intrauterine Growth | Biotech Hunter | Biotech Hunter